(1)
ASWINI S; BABU EZHUMALAI; HANUSHA V; SETHUMEENA S. A STUDY ON THE PREVALENCE OF ADVERSE EFFECTS ASSOCIATED WITH SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR DAPAGLIFLOZIN IN A TERTIARY CARE CENTRE. Asian J Pharm Clin Res 2024, 17, 147-150.